Medicare Cost Rising on PSA Screenings, Men aged 75 and above Not Deriving Benefit
The Medicare fee-for-service program has spent whooping $447 million annually on PSA screenings. But then also, a research has unveiled that men aged 75 years and above are not being benefitted.
The study carried out by the Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center has raised concern of finding out the loop hole.
Study researchers have tried to know the reason as why the above mentioned age group is not able to derive benefit. In order to do so, they have got many other things.
While carrying out the study, it has been uncovered that the prostate cancer screening cost varies across places. Lead author Xiaomei Ma with team initiated a study on elderly men having Medicare benefit. The study took place in 2006 and the volunteers, who were free from prostate cancer, were followed for three years.
In the follow-up procedure, study researchers got to know about rise in Medicare spending as well as about variation in prostate cancer screening cost.
The change was not in the basic cost of testing but in the follow-up tests. "Our results suggest that the overall cost of prostate cancer screening may be heavily influenced by how urologists choose to respond to the result of a PSA test", said Ma.
New Zealand News
- 10 pm COVID-19 curfew will negatively impact casino workers, warns BGC
- Donaco International reports H1 net loss of AU$59 million, showing significant year-on-year improvement
- Why the NZ Dollar Could Have a Very Bright Future
- Sydney’s Star Casino fined $90,000 for allowing minors to gamble in 2019
- Danville Casino Campaign being led by former Caesars CEO Tony Rodio